Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,847
Closed -$29K 293
2021
Q4
$29K Sell
1,847
-172,309
-99% -$2.77M ﹤0.01% 358
2021
Q3
$3.44M Sell
174,156
-20,462
-11% -$464K 0.02% 280
2021
Q2
$5.02M Sell
194,618
-29,277
-13% -$689K 0.02% 257
2021
Q1
$4.16M Sell
223,895
-21,206
-9% -$479K 0.02% 254
2020
Q4
$6.2M Sell
245,101
-4,450
-2% -$115K 0.03% 202
2020
Q3
$6.8M Sell
249,551
-10,743
-4% -$269K 0.04% 184
2020
Q2
$6.1M Sell
260,294
-78,368
-23% -$1.61M 0.05% 169
2020
Q1
$6.46M Sell
338,662
-2,247
-0.7% -$55.7K 0.08% 134
2019
Q4
$9.24M Sell
340,909
-1,596
-0.5% -$43K 0.1% 139
2019
Q3
$8.78M Buy
+342,505
New +$8.84M 0.1% 136

Other funds holding AFYA

Gilder Gagnon Howe & Co's AFYA Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Afya (AFYA) in Q1 2022, closing a stake of 1,847 shares — an estimated $29K sold.

Gilder Gagnon Howe & Co first reported a position in AFYA in Q3 2019 and held it in 10 quarters. The position peaked at $9.24M in Q4 2019. 53 funds tracked by Wall St. Rank hold AFYA as of Q1 2022.

  • Gilder Gagnon Howe & Co reported no remaining Afya position as of Q1 2022 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 1,847 Afya shares in Q1 2022, an estimated $29K.
  • Gilder Gagnon Howe & Co first reported a position in Afya in Q3 2019 and held it in 10 quarters.
  • Gilder Gagnon Howe & Co's Afya position peaked at $9.24M in Q4 2019.
  • 53 funds tracked by Wall St. Rank held Afya as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.